Acute Kidney Injury
Part of NephTimes
Advertisement
A study examined the associations of systolic blood pressure with mortality and hospital readmission post-AKI.
A partnership will put penKid assays in more labs for timely and precise kidney health assessment in critical care settings.
Researchers studied predictors of acute kidney injury (AKI) and mortality in a population of US veterans with COVID-19.
The JuxtaFlow RAD has shown potential to protect patients from AKI after cardiac surgery with cardiopulmonary bypass.
Patients who experienced an acute kidney injury had a greater risk of being diagnosed with dementia after the AKI incident.
Little research has focused on risk factors for and clinical outcomes of AKI in patients with SFTS.
Could IV amino acid therapy result in a lower occurrence of postoperative acute kidney injury (AKI) after cardiac surgery?
A simple risk score could help predict a patient’s susceptibility to cisplatin-associated acute kidney injury (CP-AKI).
Are kidneys from donors who had dialysis more likely to result in adverse outcomes for transplant recipients?
The FDA granted a patent to Unicycive Therapeutics for UNI-494, a drug to treat acute kidney injury (AKI).
Patients with COVID-19–associated AKI seem to have better outcomes than those with AKI related to other respiratory ...
What is the specific impact of acute kidney injury (AKI) on in-hospital mortality among octogenarian patients with COVID-19?
The FDA gave Breakthrough Device designation to the JuxtaFlow RAD to help prevent AKI during cardiothoracic surgery.
Accurate prediction of severe outcomes of acute kidney injury remains challenging.
Opinions differ on the use of no anticoagulation versus regional citrate anticoagulation for treatment of AKI with CKRT.
A baseline creatinine measurement from clinical trial enrollment may not be the best way to detect acute kidney injury.
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Patients who have acute kidney injury while hospitalized face increased risk for morbidity and mortality after discharge.
The FDA has granted a Humanitarian Device Exemption Approval Order to the Selective Cytopheretic Device Pediatric.
Patients hospitalized with COVID-19 face increased risk for long-term adverse outcomes such as major adverse kidney events.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.